Loading the map…
Private limited company registered in London, classed under “Business and domestic software development” and 2 other activities.
Headline figures
FY to Jul 2025 · Company only
Turnover
For subscribers
Profit after tax
−£163k
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
4 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2024 | 2025 |
|---|---|---|
| Profit after tax | −£163k | |
| Turnover | ||
| Net assets | ||
| Cash | ||
| Employees | ||
| Retained reserves |
Every figure for all 2 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2024 | 2025 |
|---|---|---|
| Current assets | ||
| of which debtors | ||
| of which cash | ||
| Creditors due within a year | ||
| Net current assets | ||
| Net assets | ||
| Ratios | ||
| Current ratioCurrent assets for every £1 owed within a year | ||
| Cash ratioCash for every £1 owed within a year | ||
6 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Testinium UK do?
Private limited company registered in London, classed under “Business and domestic software development” and 2 other activities.
›How much turnover does Testinium UK make?
Answered in the full report
›Is Testinium UK profitable?
No: it made a loss after tax of £163k in the year to 31 July 2025, its latest filed accounts.
›How many people work at Testinium UK?
Answered in the full report
›Where is Testinium UK based?
Its registered office is 82 St. John Street, London, EC1M 4JN, in London.
›When was Testinium UK founded?
Testinium UK Ltd was incorporated on 14 July 2023.
›Is Testinium UK still trading?
The register lists Testinium UK Ltd as active.